From 2024 to 2028, U.S. business enterprise R&D expenditure in the manufacture of medical and dental instruments and supplies is forecasted to grow steadily from $18.61 billion to $21.69 billion, expressed in 2015 PPP dollars. This suggests a compound annual growth rate (CAGR) of approximately 3.88% over the five-year period. In 2023, the expenditure was approximately $18 billion.

Future trends to watch for include:

The impact of technological advancements and digital transformation on R&D strategies.
Regulatory changes impacting medical and dental device innovation.
Evolving healthcare needs and demographic shifts that might influence R&D priorities.